Immune cells-derived exosomes: A promising strategy for COVID-19 treatment

Zichen Zhang; Jiangang Long; Lingjie Meng; Zhiwei Yang; Shengli Zhang; Lei Zhang

doi:10.1002/ctd2.138

Immune cells-derived exosomes: A promising strategy for COVID-19 treatment

Zichen Zhang
, Jiangang Long
, Lingjie Meng
, Zhiwei Yang
, Shengli Zhang
, Lei Zhang

Xi'an Jiaotong University

科研成果: 期刊稿件 › 评论/辩论

1 引用（Scopus）

源语言	英语
期刊论文编号	e138
期刊	Clinical and Translational Discovery
卷	2
期	4
DOI	https://doi.org/10.1002/ctd2.138
出版状态	已出版 - 12月 2022

访问文件

10.1002/ctd2.138

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{4bf4795d39e44adaa81d271e726e8f73,

title = "Immune cells-derived exosomes: A promising strategy for COVID-19 treatment",

keywords = "COVID-19, immune cells-derived exosomes, immune modulation, immune responses",

author = "Zichen Zhang and Jiangang Long and Lingjie Meng and Zhiwei Yang and Shengli Zhang and Lei Zhang",

year = "2022",

month = dec,

doi = "10.1002/ctd2.138",

language = "英语",

volume = "2",

journal = "Clinical and Translational Discovery",

issn = "2768-0622",

publisher = "John Wiley and Sons Inc",

number = "4",

}

TY - JOUR

T1 - Immune cells-derived exosomes

T2 - A promising strategy for COVID-19 treatment

AU - Zhang, Zichen

AU - Long, Jiangang

AU - Meng, Lingjie

AU - Yang, Zhiwei

AU - Zhang, Shengli

AU - Zhang, Lei

PY - 2022/12

Y1 - 2022/12

KW - COVID-19

KW - immune cells-derived exosomes

KW - immune modulation

KW - immune responses

UR - https://www.scopus.com/pages/publications/85165426443

U2 - 10.1002/ctd2.138

DO - 10.1002/ctd2.138

M3 - 评论/辩论

AN - SCOPUS:85165426443

SN - 2768-0622

VL - 2

JO - Clinical and Translational Discovery

JF - Clinical and Translational Discovery

IS - 4

M1 - e138

ER -